Friday, September 12, 2025
HomeIndustriesHealthcare

Healthcare

IDEAYA Announces Selection of IDE397 Phase 2 Monotherapy Expansion Dose For Global Enrollment Targeting High Priority MTAP-Deletion Solid Tumor Types

IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced selection of a monotherapy expansion dose...

HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Opportunities in Parkinson’s Disease

HanAll Biopharma and Daewoong Pharmaceutical announced the expansion of their open collaboration strategy by investing in Vincere Biosciences, a Cambridge, MA-based company developing therapeutics...

Rite Aid Names Thomas Sabatino Chief Legal Officer

Rite Aid announced that Thomas Sabatino has joined the company as Executive Vice President and Chief Legal Officer. Sabatino will play a pivotal role...

U.S. Food and Drug Administration Approves FoundationOne Liquid CDx as a Companion Diagnostic for Pfizer’s BRAFTOVI in Combination With Cetuximab to Identify Patients With...

Foundation Medicine Inc., announced that it has received approval from the U.S. Food and Drug Administration for FoundationOne Liquid CDx to be used as...

55-Provider AssociatesMD Increases Patient Engagement through eClinicalWorks EHR and healow

eClinicalWorks, the largest ambulatory cloud electronic health record (EHR), announced that AssociatesMD — a 55 provider multi-specialty physician practice with more than 12 locations...
0FansLike
0FollowersFollow
spot_img

Hot Topics